Side-by-side comparison of AI visibility scores, market position, and capabilities
Vida Health is a digital chronic disease platform covering diabetes, obesity, hypertension, and depression; raised $251.5M Series F; won 2026 MedTech Breakthrough Best Virtual Care Platform award; serves Boeing and SISC.
Vida Health is a San Francisco-based digital health company that delivers personalized, technology-driven care for chronic conditions including diabetes, obesity, hypertension, high cholesterol, and depression. Founded on the premise that managing chronic disease requires both clinical expertise and sustained behavioral change, Vida combines licensed physicians, registered dietitians, expert health coaches, and licensed therapists with a digital platform that integrates biometric devices, continuous monitoring, and synchronous video care. Members receive individualized treatment plans and connect with their care team through video visits and secure in-app messaging.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.